Medical Genetics

Building Your Care Team

At a Glance

Free sialic acid storage disease often requires coordinated care from metabolic, neurological, rehabilitation, vision, hearing, and other specialists. A medical binder with genetic, imaging, test, developmental, and therapy records can help the team plan supportive care.

Because Free Sialic Acid Storage Disease (FSASD) is an ultra-rare, multisystem condition, care cannot be managed by a single doctor. It requires a multidisciplinary care team—a group of specialists from different fields working together to support development and comfort ^[1]^[2].

In many cases, the “home base” for this team is a specialized metabolic or lysosomal storage disorder center at a major academic hospital, but local clinicians and community resources are just as vital ^[3].

The Specialist Roster

Needs will change over time, but a comprehensive care team for FSASD typically draws from the following core and as-needed specialists:

Core Specialists:

Metabolic Geneticist & Genetic Counselor: They understand the underlying biochemical process of sialic acid storage, oversee long-term management, and assist with family counseling and recurrence risk ^[3].
Neurologist: Focuses on the neurological aspects of the disease, including ataxia (coordination), spasticity (stiffness), seizures, and monitoring brain imaging ^[4]^[3].
Rehabilitation Team: Includes Physical (PT), Occupational (OT), and Speech-Language Pathologists (SLP) to address motor skills, daily living activities, and communication ^[4]^[5].
Ophthalmologist & Audiologist: Because vision and hearing are frequently affected, regular screenings are necessary ^[6].

As-Needed Specialists:

Gastroenterology & Feeding Team: Manages safe swallowing, severe reflux, constipation, and G-tube placement if needed ^[7]^[8].
Pulmonology & Sleep Medicine: Addresses sleep-disordered breathing, aspiration risks, and respiratory health.
Cardiology: Particularly important for the severe infantile form (ISSD), where cardiomegaly (enlarged heart) may occur ^[9]^[10].
Orthopedics / Physiatry: Helps manage severe spasticity, contractures, and bone/joint health.

Coordination and Support Roles:

Complex Care Coordinator: Often provided by a primary care or specialized complex care clinic, this role helps organize appointments and shares information across the many different specialists ^[11].
Palliative Care: Palliative care is not just for the end of life; it is a specialized layer of support focused on symptom management, pain relief, and goal-of-care discussions. They can be involved early to reduce the stress of a serious illness ^[11]^[12].
Social Work & Educational Support: Navigating early intervention, school accommodations (IEPs), disability resources, and respite care is a major part of the journey ^[12].

Preparing for the First Consultation

Your first appointment with a metabolic or neurology specialist is often long and information-heavy. To make the most of this time, you should bring a “medical binder” (physical or digital) containing:

Complete Genetic Reports: Bring the original, full laboratory report for the SLC17A5 gene. Ensure it includes information on whether deletion/duplication testing was performed, not just basic sequencing ^[13]^[14].
Imaging Data: Do not just bring the written report for brain MRIs. Request a CD or digital link of the actual images so the specialist can review the myelination patterns themselves ^[15]^[3].
Biochemical Results: Bring all urine or blood test results. Note if there was a severe infection present at the time of testing, as this can affect the results ^[16].
Developmental Log: A brief summary of milestones and any periods of regression ^[17]^[18].
Therapy Reports: Recent evaluations from PT, OT, or speech therapy to help the medical team understand functional abilities in daily life ^[17].

By building a team that values your observations and is connected to the broader rare-disease community, you can ensure access to the most current supportive care available ^[19]^[20].

Common questions in this guide

What specialists are usually involved in free sialic acid storage disease care?

A core team may include a doctor who specializes in inherited metabolic conditions, a genetic counselor, neurologist, physical and occupational therapists, speech-language pathologist, ophthalmologist, and audiologist. Feeding, breathing, heart, orthopedic, palliative, social-work, and educational specialists can be added as needs change.

Where should an FSASD care team be based?

Many families use a specialized metabolic or lysosomal storage disorder center at an academic hospital as the team’s home base. Local primary care clinicians, therapists, schools, and community services should remain involved so recommendations are practical and coordinated.

What should I bring to the first FSASD specialist appointment?

Bring the complete SLC17A5 genetic report, including whether deletion or duplication testing was done, actual brain MRI images rather than only the written report, and urine or blood test results. Developmental notes, regression history, and recent physical, occupational, or speech therapy reports can also help the team understand daily abilities.

Can palliative care help with FSASD before end-of-life care is needed?

Yes. Palliative care can be added early to help with symptoms, pain, comfort, family goals, and difficult decisions; it does not mean that death is near or that other treatment stops.

Who coordinates appointments and information across the FSASD team?

A complex care coordinator, primary care clinician, or specialized complex-care clinic may organize visits, share records, and help specialists work toward common goals. Families can also keep a physical or digital medical binder and ask the team how to communicate with local therapists and services.

Get notified when new evidence is published on Free sialic acid storage disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (20)

1
Neurological manifestations of lysosomal storage diseases.
Elendu C, Babawale EA, Babarinde FO, et al.
Annals of medicine and surgery (2012) 2024; (86(11)):6619-6635 doi:10.1097/MS9.0000000000002611.
PMID: 39525762
2
Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities.
Maegawa GHB
Journal of child neurology 2019; (34(6)):339-358 doi:10.1177/0883073819828587.
PMID: 30757954
3
Free sialic acid storage disorder: Progress and promise.
Huizing M, Hackbarth ME, Adams DR, et al.
Neuroscience letters 2021; (755()):135896 doi:10.1016/j.neulet.2021.135896.
PMID: 33862140
4
A 13-year follow-up of Finnish patients with Salla disease.
Paavola LE, Remes AM, Harila MJ, et al.
Journal of neurodevelopmental disorders 2015; (7(1)):20 doi:10.1186/s11689-015-9116-7.
PMID: 26171070
5
Longitudinal Characterization of the Clinical Course of Intermediate-Severe Salla Disease.
Chapleau A, Mirchi A, Tran LT, et al.
Pediatric neurology 2023; (148()):133-137 doi:10.1016/j.pediatrneurol.2023.08.013.
PMID: 37713976
6
Clinical and Genetic Characteristics of Free Sialic Acid Storage Disorder.
Wolfenson Z, Grois G, Hailemeskel RF, et al.
Journal of inherited metabolic disease 2026; (49(2)):e70148 doi:10.1002/jimd.70148.
PMID: 41879269
7
Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders.
Denny L, Coles S, Blitz R
American family physician 2017; (96(8)):515-522.
PMID: 29094891
8
Nutritional status of a group of polish children with FASD: A retrospective study.
Domin A, Mazur A
Frontiers in nutrition 2023; (10()):1111545 doi:10.3389/fnut.2023.1111545.
PMID: 37252249
9
A novel SLC17A5 variant in infantile sialic acid storage disease with hyporegenerative anemia: Neuroimaging insights and literature review.
Cappozzo F, Severino M, Gennaro E, et al.
Molecular genetics and metabolism reports 2025; (45()):101284 doi:10.1016/j.ymgmr.2025.101284.
PMID: 41459346
10
Biochemical and molecular analyses of infantile sialic acid storage disease in a patient with nonimmune hydrops fetalis.
Kang E, Kim YM, Heo SH, et al.
Clinica chimica acta; international journal of clinical chemistry 2018; (482()):199-202 doi:10.1016/j.cca.2018.04.016.
PMID: 29654786
11
Clinical characteristics of adult patients with inborn errors of metabolism in Spain: A review of 500 cases from university hospitals.
Pérez-López J, Ceberio-Hualde L, García-Morillo JS, et al.
Molecular genetics and metabolism reports 2017; (10()):92-95 doi:10.1016/j.ymgmr.2017.01.011.
PMID: 28224082
12
Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.
Cross B, Stepien KM, Gadepalli C, et al.
Frontiers in cardiovascular medicine 2022; (9()):851016 doi:10.3389/fcvm.2022.851016.
PMID: 35445089
13
Prenatal hydrops fetalis associated with infantile free sialic acid storage disease due to a novel homozygous deletion in the SLC17A5 gene.
Hasnain A, Burnett S, Agatep R, et al.
Cold Spring Harbor molecular case studies 2021; (7(5)) doi:10.1101/mcs.a006106.
PMID: 34667062
14
Atypical free sialic acid storage disorder associated with tissue specific mosaicism of SLC17A5.
Shinawi M, Wegner DJ, Paul AJ, et al.
Molecular genetics and metabolism 2025; (144(1)):109004 doi:10.1016/j.ymgme.2024.109004.
PMID: 39742826
15
Correlation between morphological MRI findings and specific diagnostic categories in fetal alcohol spectrum disorders.
Boronat S, Sánchez-Montañez A, Gómez-Barros N, et al.
European journal of medical genetics 2017; (60(1)):65-71 doi:10.1016/j.ejmg.2016.09.003.
PMID: 27620364
16
Free urinary sialic acid levels may be elevated in patients with pneumococcal sepsis.
Donoghue SE, Heath O, Pitt J, et al.
Clinical chemistry and laboratory medicine 2022; (60(11)):1855-1858 doi:10.1515/cclm-2022-0473.
PMID: 36000484
17
Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.
Wozniak JR, Riley EP, Charness ME
The Lancet. Neurology 2019; (18(8)):760-770 doi:10.1016/S1474-4422(19)30150-4.
PMID: 31160204
18
The evaluation and care of children with suspected fetal alcohol spectrum disorders in the pediatric medical home: The importance of therapeutic alliance, longitudinal surveillance and trauma-informed care.
Shah PE, Chang R, Hoyme HE
Current problems in pediatric and adolescent health care 2026; (56(1)):101912 doi:10.1016/j.cppeds.2025.101912.
PMID: 41535157
19
A rare partnership: patient community and industry collaboration to shape the impact of real-world evidence on the rare disease ecosystem.
Klein TL, Bender J, Bolton S, et al.
Orphanet journal of rare diseases 2024; (19(1)):262 doi:10.1186/s13023-024-03262-2.
PMID: 38987844
20
Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses.
Shapiro EG, Escolar ML, Delaney KA, Mitchell JJ
Molecular genetics and metabolism 2017; (122S()):8-16 doi:10.1016/j.ymgme.2017.09.007.
PMID: 29128371

This page explains how multidisciplinary care may be organized for free sialic acid storage disease for informational purposes only and does not constitute medical advice. Ask your metabolic specialist about the right referrals and monitoring for your situation.